Terns Pharmaceuticals, Inc. TERN NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score

46/100

3/6 Pass

SharesGrow Intrinsic Value

Income Statement Balance Sheet Cash Flow Statement

Annual Quarterly

Metric	TTM (2025-03 – 2025-12)
Operating Cash Flow	$-82.18M
Capital Expenditure	$0.00
Free Cash Flow	$-82.18M

People Also View

DAWN

Day One Biopharmaceuticals, Inc.

$21.46

-0.14%

AMLX

Amylyx Pharmaceuticals, Inc.

Eledon Pharmaceuticals, Inc.

$3.20

-0.62%

ABOS

Acumen Pharmaceuticals, Inc.

$2.68

+6.77%

PDSB

PDS Biotechnology Corporation

$1.06

-2.75%

MREO

Mereo BioPharma Group plc

$0.33

+2.81%

XFOR

X4 Pharmaceuticals, Inc.

$4.20

+1.69%

Terns Pharmaceuticals, Inc. TERN NASDAQ

People Also View

Get Undervalued Stock Alerts